Citation Impact
Citing Papers
Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
1996
Early indicators of prognosis in fulminant hepatic failure
1989 Standout
Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
1993 Standout
Close Relation Between Cirrhosis and Gallstones
1999
Hepatitis C: the clinical spectrum of the disease
1999
Consensus meetings on: Causality assessment of drug-induced liver injury
1988
Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload
1998
Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallenge
1993
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Acute and chronic arsenic toxicity
2003 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Material differentiation by dual energy CT: initial experience
2006 Standout
Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients
2003
Vascular disorders of the liver # †
2008 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications
2009
Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis
1994
INTERFERON-?? FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS
1998
Management of Hepatocellular Carcinoma *
2005 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Etoposide (VP 16-213) induced hepatitis. Report of three cases following standard-dose treatments
1991
On peptide bond formation, translocation, nascent protein progression and the regulatory properties of ribosomes
2003 StandoutNobel
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Gout
2016 Standout
Long-term culture of functional hepatocytes
1990
Plasma Volume in Cirrhosis of the Liver: Its Relation of Portal Hypertension, Ascites, and Renal Failure*
1967
Hepatocellular carcinoma
1991
Ecotoxicology of human pharmaceuticals
2005 Standout
Liver Transplantation
1989
Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures
1993 Standout
Interferon-α 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study
2003
Home parenteral nutrition in children: 8 years of experience with 112 patients
1990
Diclofenac Sodium
1988
Diclofenac‐induced hepatitis: case report and literature review
1994
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Adverse Effects of Macrolide Antibacterials
1993
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer
2012 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
The Incidence of Portal Vein Thrombosis At Liver Transplantation
1992
Epidemiology of cancer of the colon and rectum
1971 Standout
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
Criteria of drug-induced liver disorders
1990 Standout
Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions
1995
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Patterns of Disease Among Japanese Living in Hawaii
1970
Multivariate analysis of prognostic factors in fulminant hepatitis B
1986
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
EFFECT OF DIETARY FIBRE ON STOOLS AND TRANSIT-TIMES, AND ITS ROLE IN THE CAUSATION OF DISEASE
1972 Standout
Works of Benhamou Jp being referenced
[Primary cancer of the liver in France; 25 cases].
1958
[Prognosis of severe viral hepatitis].
1971
[Fulminating hepatitis in a woman taking glafenine and diclofenac].
1985
[Hepatitis caused by diclofenac].
1983
Criteria of selection for liver transplantation.
1987
[Irregular hepatic steatosis. Ultrasonic and computed x-ray tomographic aspects].
1983
[Cirrhosis and primary cancer of the liver].
1959
Autoimmune disorders associated with hepatitis C.
1995
[Cardiac output during liver diseases. Effects of portacaval anastomosis and diuretics].
1966
[Allopurinol-induced hepatitis. Report of a case and review of the literature (author's transl)].
1982
[Partial nodular transformation of the liver with portal hypertension].
1967
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.
1995
[Drug-induced hepatic injury].
1986
[Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
1987
Portal vin thrombosis in intrahepatic block.
1971
[Hepatitis caused by various derivatives of erythromycin].
1983
[Cirrhosis and biliary lithiasis in France: a postmortem study].
1988